Program Overview
Columbia University Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high-yield challenging scenarios in managing C3G and Immune Complex MPGN disease. The half-day conference course is designed to enhance the knowledge of healthcare professionals on pathogenesis, genetics, pathology, and genetic variants associated with C3G disease. Through lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice. The course is tailored for healthcare providers specializing in Nephrology and addressing these issues and includes talks, Q&A, and panel discussions.
Learning Objectives
-
Describe the distinct mechanisms underlying C3G and IC-MPGN, focusing on how complement dysregulation and immune complex deposition lead to these diseases.
-
Identify genetic and acquired disruptions in complement regulation and their impact on glomerular function in C3G and IC-MPGN
-
Discuss recent therapeutic advances targeting complement dysregulation, like iptacopan and pegcetacoplan, and their potential in modifying disease progression.
-
Differentiate primary IC-MPGN from secondary forms associated with systemic diseases, and identify diagnostic criteria for distinguishing these subtypes
-
Recognize the specific biopsy findings, complement assays, and genetic tests that aid in diagnosing C3G and IC GN.
-
Discuss the prevalence, risk factors, and demographic characteristics associated with C3G and IC-MPGN.
